tradingkey.logo

TELA Bio Inc

TELA
1.130USD
-0.010-0.88%
收盘 12/19, 16:00美东报价延迟15分钟
45.59M总市值
亏损市盈率 TTM

TELA Bio Inc

1.130
-0.010-0.88%

关于 TELA Bio Inc 公司

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

TELA Bio Inc简介

公司代码TELA
公司名称TELA Bio Inc
上市日期Nov 08, 2019
CEOKoblish (Antony)
员工数量209
证券类型Ordinary Share
年结日Nov 08
公司地址1 Great Valley Parkway, Suite 24
城市MALVERN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编19355
电话14843202930
网址https://www.telabio.com/
公司代码TELA
上市日期Nov 08, 2019
CEOKoblish (Antony)

TELA Bio Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-21.60%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+1318.24%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-27.72%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+126.79%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+126.79%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+126.79%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
11.93K
--
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. William Plovanic
Mr. William Plovanic
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-21.60%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+1318.24%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-27.72%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+126.79%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+126.79%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+126.79%

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
业务USD
名称
营收
占比
OviTex
24.60M
63.53%
OviTex PRS
13.38M
34.55%
Other
744.00K
1.92%
由于公司未披露,未能获取相关数据
业务
地区
业务USD
名称
营收
占比
OviTex
24.60M
63.53%
OviTex PRS
13.38M
34.55%
Other
744.00K
1.92%

股东统计

更新时间: 11月15日 周六
更新时间: 11月15日 周六
持股股东
股东类型
持股股东
持股股东
占比
EW Healthcare Partners
17.62%
Nantahala Capital Management, LLC
11.68%
North Run Capital, LP
8.41%
Lytton (Laurence W)
6.55%
SilverArc Capital Management, LLC
6.36%
其他
49.38%
持股股东
持股股东
占比
EW Healthcare Partners
17.62%
Nantahala Capital Management, LLC
11.68%
North Run Capital, LP
8.41%
Lytton (Laurence W)
6.55%
SilverArc Capital Management, LLC
6.36%
其他
49.38%
股东类型
持股股东
占比
Hedge Fund
33.32%
Venture Capital
17.62%
Investment Advisor
9.79%
Investment Advisor/Hedge Fund
8.67%
Individual Investor
8.59%
Research Firm
1.77%
其他
20.24%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
171
28.74M
72.54%
-9.88M
2025Q2
185
33.40M
84.44%
-6.87M
2025Q1
191
33.22M
84.09%
-7.97M
2024Q4
187
31.75M
80.76%
+976.11K
2024Q3
178
22.55M
84.95%
-6.37M
2024Q2
170
20.61M
83.03%
-5.54M
2024Q1
157
22.19M
89.70%
-5.95M
2023Q4
151
21.96M
89.44%
-4.89M
2023Q3
146
22.32M
90.91%
-4.91M
2023Q2
142
22.34M
91.32%
+1.25M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
EW Healthcare Partners
4.11M
10.38%
--
--
Jun 30, 2025
Nantahala Capital Management, LLC
5.11M
12.9%
-1.00
-0.00%
Jun 30, 2025
North Run Capital, LP
3.68M
9.3%
+1.70M
+85.75%
Mar 31, 2025
Lytton (Laurence W)
2.72M
6.88%
+271.93K
+11.09%
Jun 30, 2025
SilverArc Capital Management, LLC
2.78M
7.02%
+8.51K
+0.31%
Jun 30, 2025
Stonepine Capital Management, LLC
2.08M
5.26%
+28.54K
+1.39%
Jun 30, 2025
The Vanguard Group, Inc.
1.91M
4.83%
-16.59K
-0.86%
Jun 30, 2025
Dafna Capital Management, LLC
1.44M
3.64%
--
--
Jun 30, 2025
Perkins Capital Management, Inc.
875.87K
2.21%
-34.75K
-3.82%
Jun 30, 2025
Citi Investment Research (US)
750.00K
1.89%
--
--
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
占比0.01%
ProShares Hedge Replication ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
iShares Russell 2000 ETF
占比0%
Global X Russell 2000 ETF
占比0%
Global X Russell 2000 Covered Call ETF
占比0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0%
ProShares UltraPro Russell2000
占比0%
Proshares Ultra Russell 2000
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

TELA Bio Inc的前五大股东是谁?

TELA Bio Inc 的前五大股东如下:
EW Healthcare Partners持有股份:4.11M,占总股份比例:10.38%。
Nantahala Capital Management, LLC持有股份:5.11M,占总股份比例:12.90%。
North Run Capital, LP持有股份:3.68M,占总股份比例:9.30%。
Lytton (Laurence W)持有股份:2.72M,占总股份比例:6.88%。
SilverArc Capital Management, LLC持有股份:2.78M,占总股份比例:7.02%。

TELA Bio Inc的前三大股东类型是什么?

TELA Bio Inc 的前三大股东类型分别是:
EW Healthcare Partners
Nantahala Capital Management, LLC
North Run Capital, LP

有多少机构持有TELA Bio Inc(TELA)的股份?

截至2025Q3,共有171家机构持有TELA Bio Inc的股份,合计持有的股份价值约为28.74M,占公司总股份的72.54%。与2025Q2相比,机构持股有所增加,增幅为-11.90%。

哪个业务部门对TELA Bio Inc的收入贡献最大?

在FY2025Q2,OviTex业务部门对TELA Bio Inc的收入贡献最大,创收24.60M,占总收入的63.53%。
KeyAI